Meet DIVERSA at Key Biotech & Life Sciences Events – May 2026 May is a key month for innovation and partnering in biotech, nutraceuticals and life sciences. DIVERSA Technologies will be attending three major European events, actively engaging through partnering platforms and 1:1 meetings to [...]
Europe is leading a strategic transition towards personalized and precision medicine, driven by the need to improve outcomes, reduce adverse effects, and increase efficiency in healthcare. In this context, nanomedicine is emerging as a key enabler, offering tools for precise, safe, and scalable delivery of therapeutic [...]
Lipid nanoparticles are transforming rare disease treatment by enabling targeted mRNA and gene therapies. Learn how nanomedicine drives personalized, point-of-care solutions. The rare disease dilemma More than 300 million people worldwide live with a rare disease. Most of them face a long diagnostic journey, limited [...]
Nanotechnology is revolutionizing medical imaging, enhancing sensitivity, targeting, and resolution. Discover how nanoscale tools are unlocking the next generation of precision diagnostics. Imaging: the foundation of precision medicine In precision medicine, seeing clearly is the first step toward treating precisely. Whether diagnosing cancer, [...]
Discover how next-generation lipid nanoparticles (LNPs) are revolutionizing Gene Editing by enabling safe, precise, and efficient delivery of CRISPR and RNA-based tools. Gene Editing is ready, and delivery is allowing translation Gene Editing has entered the golden era. Technologies like CRISPR-Cas9, base editors, and prime editors are [...]
Discover how lipid nanoparticles (LNPs) are powering a new era of personalized nanomedicine. Nanoparticle delivery systems are making bedside RNA therapies a reality. A paradigm shift: from mass production to personalized RNA therapies Imagine a future where life-saving RNA therapies are not manufactured [...]
The journey from scientific discovery to patient benefit is often long and uncertain. But in recent years, lipid nanoparticles (LNPs) have emerged as a key enabler for accelerating the clinical translation of innovative therapies, including mRNA, proteins, peptides, and gene-editing tools. At DIVERSA, we are designing next-generation nanoparticles that [...]
While nanotechnology is widely recognized for its transformative role in medicine, its impact extends well beyond pharmaceuticals. The nutraceutical and cosmetic industries are increasingly turning to nanotechnology to enhance the efficacy, stability, and bioavailability of their products. From encapsulated vitamins to targeted skin delivery systems, the application of lipid nanoparticles and other nanocarriers, such as liposomes, [...]
The future of monoclonal antibody delivery with Lipid Nanoparticles Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering targeted therapies for cancer, autoimmune diseases, and infectious diseases. However, their clinical potential is often hindered by challenges related to stability, bioavailability, and delivery efficiency. Traditional delivery [...]
Discover how nanoparticles are revolutionizing medical diagnostics, enabling early disease detection with greater precision and sensitivity. From oncology to neurological disorders, these innovations enhance imaging and personalize treatments. DIVERSA is driving the future of diagnostics with lipid nanoparticles for PET, SPECT, MRI, and fluorescence, advancing [...]
